SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950116-01-501010
Filing Date
2001-10-26
Accepted
2001-10-26 00:00:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A sc13d-a.txt SC 13D/A 12478
3 EX-1 ex-1.txt EX-1 2942
  Complete submission text file 0000950116-01-501010.txt   16955
Mailing Address 425 WOODSMILL RD ST LOUIS MO 63017
Business Address 425 WOODSMILL RD ST LOUIS MO 63017 3145799899
SHEFFIELD PHARMACEUTICALS INC (Subject) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50777 | Film No.: 1766973
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address VIA INDUSTRIA I CADEMPINO V8 00000 2018962200
INPHARZAM INTERNATIONAL S A (Filed by) CIK: 0001064797 (see all company filings)